Mario Giuliani
Directeur/Membre du Conseil chez ROYALTY PHARMA PLC
Fortune : 311 M $ au 30/04/2024
Postes actifs de Mario Giuliani
Sociétés | Poste | Début | Fin |
---|---|---|---|
HBM HEALTHCARE INVESTMENTS AG | Directeur/Membre du Conseil | 01/01/2012 | - |
ROYALTY PHARMA PLC | Directeur/Membre du Conseil | 01/06/2020 | - |
Independent Dir/Board Member | 01/06/2020 | - | |
NGR Luxembourg SA | Directeur/Membre du Conseil | - | - |
Nogra Pharma Invest SARL | Directeur/Membre du Conseil | - | - |
MIKA Pharma GmbH
MIKA Pharma GmbH Pharmaceuticals: MajorHealth Technology MIKA Pharma GmbH develops and produces dermal, transdermal and buccal application systems. It serves pharmaceuticals on the basis of sprayable liposomes, pre-liposomal solutions and proprietary micellar nano-solutions. The company was founded in 1994 and is headquartered in Speyer, Germany. | Directeur Général | - | - |
Nogra Real Estate SARL | Directeur/Membre du Conseil | - | - |
Nogra Private Equity SARL | Directeur/Membre du Conseil | - | - |
Giuliani Group SpA
Giuliani Group SpA Financial ConglomeratesFinance Giuliani Group SpA operates as an investment holding company. The company is headquartered in Milan, Italy. | Directeur/Membre du Conseil | - | - |
GISEV Group Lux SA
GISEV Group Lux SA Financial ConglomeratesFinance GISEV Group Lux SA is an investment holding Luxembourger company founded in 2018. The private company is based in Luxembourg, Luxembourg. | Directeur/Membre du Conseil | - | - |
░░░ ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Historique de carrière de Mario Giuliani
Anciens postes connus de Mario Giuliani
Sociétés | Poste | Début | Fin |
---|---|---|---|
░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
░░░░░░░░ | - | - | |
░░░░░░░░ ░░ ░░░░░░░░░░░ | - | - | |
░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Mario Giuliani
Università Cattolica del Sacro Cuore Campus di Milano | Undergraduate Degree |
Statistiques
Internationale
Luxembourg | 7 |
Etats-Unis | 5 |
Italie | 5 |
Opérationnelle
Director/Board Member | 15 |
Chief Executive Officer | 2 |
Independent Dir/Board Member | 2 |
Sectorielle
Health Technology | 8 |
Finance | 6 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
RECORDATI | Health Technology |
ROYALTY PHARMA PLC | Health Technology |
Entreprise privées | 16 |
---|---|
Mosaix Ventures LLC
Mosaix Ventures LLC Investment ManagersFinance Mosaix Ventures LLC (Mosaix Ventures) is a private equity and venture capital firm founded in 2000 by Ranjan Lal. The firm is headquartered in Chicago, Illinois. | Finance |
Giuliani SpA
Giuliani SpA Pharmaceuticals: MajorHealth Technology Giuliani SpA manufactures and distributes health and beauty products. It develops products and has contributed to promoting pharmaceutical awareness among the public, becoming one of Italy's pharmaceutical manufacturers. The company was founded in 1889 by Germano Giuliani and is headquartered in Milan, Italy. | Health Technology |
ElevateBio LLC
ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Health Technology |
HBM Healthcare Investments AG
HBM Healthcare Investments AG Investment ManagersFinance HBM Healthcare Investments AG is a listed investment company which invests worldwide, primarily focusing on Europe, Asia and North America, in private and public companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas. It aims to invest mainly in a form of equity, but also considers convertible bonds, debt securities and derivatives. The investment focus is on later stage companies, and participates in follow-on investment rounds, also acquiring majority stake in target companies. It invests also in other funds. | Finance |
Fair-Med Healthcare AG
Fair-Med Healthcare AG Pharmaceuticals: OtherHealth Technology Fair-Med Healthcare AG manufactures generic medicines. It offers prescription and over-the-counter drugs across several therapeutic segments. The company was founded in 2012 and is headquartered in Zug, Switzeland. | Health Technology |
Jukka LLC | |
MGG Capital SAM
MGG Capital SAM Financial ConglomeratesFinance MGG Capital SAM is a Monegasque private investment company founded by Mario Germano Giuliani. The company's focus and activities are not specified in the provided metadata. | Finance |
NGR Luxembourg SA | |
GISEV Group Lux SA
GISEV Group Lux SA Financial ConglomeratesFinance GISEV Group Lux SA is an investment holding Luxembourger company founded in 2018. The private company is based in Luxembourg, Luxembourg. | Finance |
Giuliani Group SpA
Giuliani Group SpA Financial ConglomeratesFinance Giuliani Group SpA operates as an investment holding company. The company is headquartered in Milan, Italy. | Finance |
Nogra Private Equity SARL | |
Nogra Real Estate SARL | |
MIKA Pharma GmbH
MIKA Pharma GmbH Pharmaceuticals: MajorHealth Technology MIKA Pharma GmbH develops and produces dermal, transdermal and buccal application systems. It serves pharmaceuticals on the basis of sprayable liposomes, pre-liposomal solutions and proprietary micellar nano-solutions. The company was founded in 1994 and is headquartered in Speyer, Germany. | Health Technology |
Nogra Group SA | |
Nogra Pharma Invest SARL | |
Nogra Pharma Ltd.
Nogra Pharma Ltd. Pharmaceuticals: MajorHealth Technology Nogra Pharma Ltd. operates as a pharmaceutical company. It offers brand which include Lialda and Mezavant. The firm focuses on the treatment of ulcerative colitis and crohn's disease. The company was founded in 2005 and is headquartered in Dublin, Ireland. | Health Technology |
- Bourse
- Insiders
- Mario Giuliani
- Expérience